Animalcare Group schedules 2025 AGM following annual report

Published 16/05/2025, 07:26
Animalcare Group schedules 2025 AGM following annual report

LONDON - Animalcare Group plc (AIM:ANCR), an international animal health company, announced today the publication of its 2024 Annual Report and the scheduling of its Annual General Meeting (AGM) for June 10, 2024. The meeting is set to take place at the offices of Squire Patton Boggs LLP in London.

The company, which is listed on the UK’s AIM stock market, operates across seven European countries, Australia, and New Zealand, and exports to approximately 40 countries globally. Animalcare focuses on the development, partnership, and acquisition of new and innovative products in the veterinary sector.

Electronic copies of the 2024 Annual Report are to be made available on the company’s website, while printed versions have been dispatched to registered shareholders preferring paper communications.

The upcoming AGM will provide an opportunity for shareholders to engage with the management on the company’s performance and future plans. The notice for the AGM has been issued alongside the annual report, as per regulatory requirements.

The company’s leadership, including CEO Jenny Winter and CFO Chris Brewster, remains available for media and investor relations inquiries. Animalcare has also listed its corporate finance and banking advisors, Stifel Nicolaus Europe Limited and Panmure Liberum, respectively, and its communications firm, Alma Strategic Communications, for further contact.

This announcement, based on a press release statement, comes as Animalcare Group continues to establish itself within the animal health industry, aiming to expand its product offerings and market reach. The information provided does not include specific financial performance data or details on the company’s strategic initiatives, which are typically reserved for discussion during the AGM and detailed within the annual report.

Investors and stakeholders are encouraged to review the annual report for a comprehensive understanding of Animalcare’s financial health and strategic direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.